Fire Capital Management LLC Buys Shares of 3,587 Danaher Co. (NYSE:DHR)

Fire Capital Management LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,587 shares of the conglomerate's stock, valued at approximately $823,000.

Other institutional investors have also made changes to their positions in the company. Norges Bank bought a new position in shares of Danaher in the fourth quarter valued at approximately $2,130,740,000. Raymond James Financial Inc. bought a new stake in shares of Danaher during the 4th quarter worth $391,172,000. Two Sigma Advisers LP grew its stake in Danaher by 4,248.8% in the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after buying an additional 1,601,800 shares during the last quarter. Capital World Investors raised its holdings in Danaher by 32.7% in the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after acquiring an additional 1,566,658 shares during the period. Finally, Point72 Asset Management L.P. lifted its position in Danaher by 460.6% during the 4th quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock worth $309,558,000 after acquiring an additional 1,107,998 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Danaher Price Performance

Shares of DHR traded down $0.33 during mid-day trading on Monday, reaching $189.57. The company had a trading volume of 1,067,250 shares, compared to its average volume of 3,470,497. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market capitalization of $135.67 billion, a P/E ratio of 35.89, a P/E/G ratio of 2.66 and a beta of 0.80. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The company's 50-day moving average is $192.72 and its 200-day moving average is $213.41.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. On average, equities analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's dividend payout ratio (DPR) is 24.85%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DHR. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Sunday. Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price on the stock in a report on Friday, March 14th. Jefferies Financial Group cut their price target on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a report on Tuesday, April 22nd. Guggenheim reissued a "buy" rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Finally, UBS Group dropped their target price on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $263.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.